Pro Dex Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Pro Dex Inc in the first quarter 2026?
Pro dex Inc achieved a return on average equity (ROE) of 26.18 % in its first quarter 2026, this is above PDEX's average return on equity of 17.86%.
Pro Dex Inc shareholder's equity over the 12 months ending in its first quarter 2026 are valued at $46 million

ROE fell compared to the fourth quarter 2026, despite the net income growth of 6.69% from the fourth quarter 2026.

Within the Medical Equipment & Supplies industry 10 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 397, from total ROE ranking in the fourth quarter 2026 at 422.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) I. Quarter	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter
Y / Y Equity Change	18.87 %	30.03 %	28.1 %	30.82 %	-
Y / Y Net Income Change	-34.87 %	138.68 %	20.24 %	7.21 %	89.78 %
Net Income (TTM) in Millions	12	14	12	11	11
Return On Equity (TTM)	26.18 %	31.05 %	29.1 %	29.25 %	30.82 %
PDEX's Total Ranking	# 397	# 422	# 65	# 136	#
Equity (TTM) in Millions	49	48	45	42	42
Seq. Equity Change	3.6 %	5.39 %	8.57 %	0.28 %	13.32 %
Seq. Net Income Change	6.69 %	-27.45 %	80.06 %	-53.27 %	290.98 %

Back to PDEX Management Effectiveness >> PDEX's 5 Years Annual ROE >> Compare PDEX ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 11
Sector	# 59
Overall	# 397

Return On Equity Statistics
High	Average	Low
45.74 %	17.86 %	-20.02 %
(Mar 31 2017)		(Jun 30 2013)

PDEX Annual Return On Equity	(Jun 30 2026) 2026	(Jun 30 2025) 2025	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022
Total Equity in Millions	48	37	31	32	24
Y / Y Equity Change	30.03 %	18.68 %	-2.29 %	33.47 %	17.85 %
Net Income in Millions	14	9	2	7	4
Y / Y Net Income Change	52.17 %	322.1 %	-69.93 %	83.5 %	-13.37 %
Return On Equity	28.68 %	24.51 %	6.89 %	22.39 %	16.29 %

Back to PDEX Management Effectiveness >> PDEX's 5 Years Annual ROE >> Compare PDEX ROE to its Competitors

Annual Roe Comment

In 2026 ROE improved to 28.68 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PDEX's' Return on Equity at Yahoo Finance
PDEX's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for PDEX's Competitors
Subscribers only: Roe for Pro Dex Inc 's Suppliers
Subscribers only: Return On Equity for PDEX's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Idexx Laboratories Inc	71.18 %
Tenet Healthcare Corp	57.13 %
Aurinia Pharmaceuticals Inc	51.92 %
Nurix Therapeutics Inc	49.34 %
Carlisle Companies Incorporated	44.18 %
Bristol myers Squibb Company	43.83 %
Zevra Therapeutics Inc	38.02 %
Dexcom Inc	36.56 %
Rallybio Corporation	36.35 %
Caredx Inc	34.08 %
Chemed Corporation	32.10 %
Illumina Inc	31.45 %
Transmedics Group Inc	28.74 %
Acadia Pharmaceuticals Inc	28.03 %
Pro dex Inc	26.91 %
Sotera Health Company	26.41 %
Pacs Group Inc	25.65 %
Standard Biotools Inc	25.58 %
Resmed Inc	25.50 %
Bioventus Inc	24.60 %
Encompass Health Corporation	24.08 %
Iradimed Corporation	23.90 %
Corcept Therapeutics Inc	22.88 %
Msa Safety Inc	21.79 %
Lantheus Holdings Inc	21.72 %
Iqvia Holdings Inc	21.40 %
Denali Therapeutics Inc	21.40 %
West Pharmaceutical Services Inc	21.08 %
Brightspring Health Services Inc	20.31 %
Healthcare Services Group Inc	20.22 %

Date modified: 2026-10-30T13:19:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.